Since the very beginning of the war in Ukraine, Egis Pharmaceuticals PLC has been committed to helping and supporting those in need in all possible ways.

Egis has been present in Ukraine for more than 20 years – its representative office has become an important player for supplying the country with medicines since its opening in 1999. Egis helps its colleagues in Ukraine in every way it can and provides humanitarian aid to Ukrainian patients in the current situation.

Standing together has never been so crucial for the Egis family than in these difficult times.

Two technology-intensive developments, carried out with state subsidies, were completed at Egis Pharmaceuticals PLC’s Körmend site (Hungary). The investments were inaugurated by Péter Szijjártó, Minister of Foreign Affairs and Trade, and by the company’s CEO, Dr. István Hodász on 15 October.  In addition to a new packaging plant, Egis has also established a plant with special knowledge and technology requirements, typically suitable to manufacture oncology products.  Thus, Egis is now able to implement all value-creating processes within the field of oncology, from development to active ingredient and finished product manufacturing.

We have commemorated World Cancer Day.

Egis today is among the Top50 foreign companies operating in Vietnam.

The performance of the Hungarian pharmaceutical industry in the last ‘peaceful year’ before the coronavirus epidemic was reviewed in a comprehensive analysis by Nézőpont Institute on behalf of 16 pharmaceutical companies of the Hungarian Pharmaceutical Manufacturers Association (MAGYOSZ).

Disinfection plays an important role in reducing the risk of infection. As a responsible company, Egis supports the safe operation of pharmacies in the second wave of the coronavirus pandemic as well.

On the occasion of the national holiday, Dr. István Hodász, CEO of Egis was granted the award ‘For the Hungarian Economy’ by Deputy Prime Minister and Minister of Finance Mihály Varga. The award is the most prestigious recognition to be given by the Minister of Finance on ministerial level for outstanding excellence and contribution to the Hungarian economy.

The Semmelweis University and Egis Pharmaceuticals PLC have agreed on an even closer cooperation than before. Our common goal is to further raise the standards of pharmaceutical R+D as well as pharmacist and doctor training by making use of the synergies in each other’s activities. As a result of the agreement, new health industrial innovations can be launched and the Semmelweis University can be extended with more practical educational and training elements that also meet the needs of the Hungarian pharmaceutical industry.

One of Egis’ core values is care – with our immediate surroundings as well as in a wider sense. As a responsible company, we strive to support such projects that serve people’s safety and comfort. In this spirit, Egis decided to support the construction of a safe bicycle railroad crossing that is used also by many of our employees daily on their way to our Körmend plant.